JP2017517255A5 - - Google Patents

Download PDF

Info

Publication number
JP2017517255A5
JP2017517255A5 JP2016568573A JP2016568573A JP2017517255A5 JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5 JP 2016568573 A JP2016568573 A JP 2016568573A JP 2016568573 A JP2016568573 A JP 2016568573A JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5
Authority
JP
Japan
Prior art keywords
particles
micronized
diameter
jelly
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016568573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017517255A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/032078 external-priority patent/WO2015179711A1/en
Publication of JP2017517255A publication Critical patent/JP2017517255A/ja
Publication of JP2017517255A5 publication Critical patent/JP2017517255A5/ja
Priority to JP2020096350A priority Critical patent/JP7304316B2/ja
Pending legal-status Critical Current

Links

JP2016568573A 2014-05-21 2015-05-21 微粉化ホウォートンゼリー Pending JP2017517255A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020096350A JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462001600P 2014-05-21 2014-05-21
US62/001,600 2014-05-21
PCT/US2015/032078 WO2015179711A1 (en) 2014-05-21 2015-05-21 Micronized wharton's jelly

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020096350A Division JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Publications (2)

Publication Number Publication Date
JP2017517255A JP2017517255A (ja) 2017-06-29
JP2017517255A5 true JP2017517255A5 (enExample) 2018-06-14

Family

ID=54554801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016568573A Pending JP2017517255A (ja) 2014-05-21 2015-05-21 微粉化ホウォートンゼリー
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Country Status (5)

Country Link
US (1) US20150335686A1 (enExample)
EP (1) EP3146039A4 (enExample)
JP (2) JP2017517255A (enExample)
AU (2) AU2015264025A1 (enExample)
WO (1) WO2015179711A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5505760B2 (ja) 2005-09-27 2014-05-28 ティッシュテク・インコーポレーテッド 羊膜調製物及び精製組成物及びその使用方法
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
US9682044B2 (en) 2011-06-10 2017-06-20 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
EP3167049A4 (en) * 2014-07-08 2017-11-29 MIMEDX Group Inc. Micronized wharton's jelly
US10201573B1 (en) * 2014-10-27 2019-02-12 Brahm Holdings, Llc Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
US10342831B2 (en) 2015-05-20 2019-07-09 Tissuetech, Inc. Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
CA3050082A1 (en) 2016-04-04 2017-10-12 Omeza LLC Fish oil topical composition
EP3474869B1 (en) * 2016-06-24 2025-04-09 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
FR3070262B1 (fr) 2017-08-23 2020-10-16 Tbf Genie Tissulaire Tbf Composition comprenant de la gelee de wharton, procede de preparation et utilisations
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
CA3076485A1 (en) * 2017-09-19 2019-03-28 Gary M. Petrucci Amnion tissue preparations and methods of using
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
JP7463273B2 (ja) * 2017-10-19 2024-04-08 ライフセル コーポレーション 流動性無細胞組織マトリックス製品および製造方法
US20220275416A1 (en) * 2019-08-08 2022-09-01 Tissue Regeneration Therapeutics Inc. Perivascular lysates and uses thereof
EP4117626A1 (en) * 2020-03-12 2023-01-18 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
US11844876B2 (en) 2021-01-25 2023-12-19 BioStem Tehcnologies, Inc. Two-part clotting composition and methods of making and using thereof
CZ309798B6 (cs) * 2022-03-15 2023-10-18 Prime Cell Bioscience, a.s Způsob přípravy biologického léčivého přípravku na bázi perinatální tkáně, práškový materiál a jeho použití
US20250262249A1 (en) * 2022-04-20 2025-08-21 Biostem Technologies, Inc. Multi-part processed human amniotic composition and methods of making and using thereof for treatment of peyronie's disease
JP2025524108A (ja) * 2022-07-26 2025-07-25 バイオステム テクノロジーズ，インコーポレイテッド 関節内治療のためのヒト臍帯組成物および方法
US20240226181A1 (en) * 2023-01-11 2024-07-11 Biostem Technologies, Inc. Human umbilical cord composition for treatment of peyronie's disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) * 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
US9005646B2 (en) * 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8071135B2 (en) * 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
CA2739166C (en) * 2008-10-10 2013-12-31 Julio Font Perez New biomaterial from wharton's jelly of the human umbilical cord
CN102198292B (zh) * 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
AU2010350075B2 (en) * 2010-03-30 2016-03-03 Histocell, S.L. New biomaterial from Wharton's jelly umbilical cord
WO2012112410A2 (en) * 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
EP3744336B1 (en) * 2011-02-14 2025-01-01 MiMedx Group, Inc. Micronized placental tissue compositions and methods for making and using the same
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
DK3321355T3 (da) * 2011-12-30 2021-11-08 Amit Patel Fremgangsmåder og sammensætninger til klinisk afledning af en allogen celle og terapeutiske anvendelser
WO2014028657A1 (en) * 2012-08-15 2014-02-20 Mimedx Group, Inc Reinforced placental tissue grafts and methods of making and using the same
US8904664B2 (en) * 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
JP2016529070A (ja) * 2013-09-10 2016-09-23 ミメディクス グループ インコーポレイテッド 成形胎盤組成物の美容的使用

Similar Documents

Publication Publication Date Title
AU2015287920A8 (en) Micronized Wharton's Jelly
JP2006181365A (ja) 半合成の血小板ゲル及びその調製方法
US9814746B2 (en) Method of treatment utilizing an acellular amnion derived therapeutic composition
JP2019509387A (ja) ジェランガムヒドロゲル、調製物、方法、およびそれらの使用
JP2016216487A5 (enExample)
JP2019513136A5 (enExample)
ME02868B (me) POSTUPCI, CEV, l UREĐAJ ZA DOBIJANJE KOMPOZICIJE ZA ZARASTANJE RANA
JP2013527217A5 (enExample)
MX388111B (es) Metodo y composicion para producir agentes regenerativos anti-inflamatorios/anti-catabolicos mejorados a partir de fluido fisiologico autologo.
WO2013096792A1 (en) Method for repairing or replacing damaged tissue
CN103446624A (zh) 载药微球/壳聚糖/海藻酸钠可注射水凝胶的制备方法
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
HRP20161138T1 (hr) Farmaceutski pripravak za oralnu primjenu
JP2021500092A5 (enExample)
JP2017507145A5 (enExample)
JP2013173780A5 (enExample)
Zhang et al. Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review
US20190022136A1 (en) Micron-sized gold, kit comprising said gold and its use as a non-toxic immune suppressor as well as gold implants
RU2017129375A (ru) Интестинальный гель на основе леводопы и карбидопы и способы его применения
JP2013520271A5 (enExample)
MX380536B (es) Composicion y metodo para tratar la enfermedad de chagas.
CN104524633B (zh) 一种基于肌肉的神经支架及其制备方法
US20190343983A1 (en) Scaffold compositions for tissue repair
RU2015133365A (ru) Альфа-2 адренергический агонист для лечения внутриглазного давления и заболеваний глаз путем введения в стекловидное тело и внутрикамерно
US20220143268A1 (en) Novel bone putty compositions and methods of use thereof